Search Results - "Atchley, William T"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study by Burger, Barrett J, Epps, Sarenthia M, Cardenas, Victor M, Jagana, Rajani, Meena, Nikhil K, Atchley, William T

    Published in Life (Basel, Switzerland) (01-08-2023)
    “…Research Question: Does treatment with tocilizumab increase the risk of a fungal infection in critically ill patients with coronavirus-19? Background: Numerous…”
    Get full text
    Journal Article
  2. 2

    Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction by Owens, S Michael, Atchley, William T, Hambuchen, Michael D, Peterson, Eric C, Gentry, W Brooks

    Published in CNS & neurological disorders drug targets (01-12-2011)
    “…Developing specific medications to treat (+)-methamphetamine (METH) addiction is a difficult challenge because METH has multiple sites of action that are…”
    Get more information
    Journal Article
  3. 3

    Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions by Atchley, William T, Kakkera, Teja Krishna

    Published in Current opinion in pulmonary medicine (01-03-2024)
    “…Despite the advent of effective and mechanistically diverse treatments for pulmonary arterial hypertension (PAH) and their positive impacts on the functional…”
    Get full text
    Journal Article
  4. 4

    Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North Carolina by Atchley, William T, Alvarez, Carolina, Saxena-Beem, Shruti, Schwartz, Todd A, Ishizawar, Rumey C, Patel, Kunal P, Rivera, M Patricia

    Published in Chest (01-08-2021)
    “…Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer and have expanded use in small cell lung cancer. Although…”
    Get full text
    Journal Article
  5. 5

    Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine by Peterson, Eric C, Laurenzana, Elizabeth M, Atchley, William T, Hendrickson, Howard P, Owens, S Michael

    “…Chronic or excessive (+)-methamphetamine (METH) use often leads to addiction and toxicity to critical organs like the brain. With medical treatment as a goal,…”
    Get more information
    Journal Article
  6. 6

    Ageing and chronic obstructive pulmonary disease: interrelationships by Kakkera, Krishna, Atchley, William T., Kodali, Maneetha, Bartter, Thaddeus

    Published in Current opinion in pulmonary medicine (01-03-2023)
    “…As life expectancy increases, the ageing population accrues an increasing burden of chronic conditions and functional compromise. Some conditions that lead to…”
    Get full text
    Journal Article
  7. 7

    Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy by White, Sarah J, Hendrickson, Howard P, Atchley, William T, Laurenzana, Elizabeth M, Gentry, W Brooks, Williams, D Keith, Owens, S Michael

    Published in Drug metabolism and disposition (01-08-2014)
    “…We hypothesized that treatment of pregnant rat dams with a dual reactive monoclonal antibody (mAb4G9) against (+)-methamphetamine [METH; equilibrium…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer by Atchley, William T., Alvarez, Carolina, Saxena-Beem, Shruti, Schwartz, Todd A., Ishizawar, Rumey C., Patel, Kunal P., Rivera, M. Patricia

    Published in Chest (01-08-2021)
    “…Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer and have expanded use in small cell lung cancer. Although…”
    Get full text
    Journal Article
  11. 11
  12. 12